David M. Kendall

David M. Kendall

Chief Tech/Sci/R&D Officer bei ZEALAND PHARMA A/S

62 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

David M.
Kendall
is currently the Chief Medical Officer at Zealand Pharma A.
Prior to this, he worked as the Chief Medical Officer at MannKind Corp.
from 2018 to 2020, and as the Vice President-Global Medical Affairs at Eli Lilly & Co. from 2011 to 2018.
He also served as the Medical Director at Amylin Pharmaceuticals, Inc. from 2005 to 2008, and as the Medical Director at the International Diabetes Center from 1997 to 2009.
Additionally, he was the Chief Scientific & Medical Affairs Officer at the American Diabetes Association from 2009 to 2011.
Kendall's education includes an undergraduate degree from St. Olaf College in 1983 and a doctorate from the University of Minnesota in 1988.

Aktive Positionen von David M. Kendall

UnternehmenPositionBeginn
ZEALAND PHARMA A/S Chief Tech/Sci/R&D Officer 02.06.2022
Alle aktiven Positionen von David M. Kendall

Ehemalige bekannte Positionen von David M. Kendall

UnternehmenPositionEnde
MANNKIND CORPORATION Chief Tech/Sci/R&D Officer 28.08.2020
ELI LILLY AND COMPANY Corporate Officer/Principal 01.02.2018
Lilly Diabetes Corporate Officer/Principal 01.01.2018
Chief Tech/Sci/R&D Officer 01.07.2011
Chief Tech/Sci/R&D Officer 01.09.2009
Sehen Sie sich die Erfahrung von David M. Kendall im Detail an

Ausbildung von David M. Kendall

St. Olaf College Undergraduate Degree
University of Minnesota Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David M. Kendall im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
ELI LILLY AND COMPANY

Health Technology

MANNKIND CORPORATION

Health Technology

ZEALAND PHARMA A/S

Health Technology

Private Unternehmen5

Health Technology

Commercial Services

Health Services

Commercial Services

Lilly Diabetes

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. David M. Kendall